The mouse has several distinct advantages as an experimental model for study of the cochlcar blood flow (CBF) in the mammal, particularly for studies involving genetic manipulation, development and aging factors. In this investigation wc evaluated the effects of selected vasodilating agents on CBF using laser-Doppler flowmetry. Sodium nitroprussidc. hydralazinc and pcntoxifylline were applied topically on the round window (RW) or systemically by a subcutaneous injection. Topical application of sodium nitroprusside and hydralazine elevated CBF significantly, while systemic administrations of these two drugs failed to elevate CBF consistently.
Introduction
The mouse has several distinct advantages as an experimental model for human auditory function. Various genetic mouse models exist for conditions resembling human auditory disorders. Moreover, the mouse is a suitable animal for studies of the effects of aging on hearing, because life span of the mouse is relatively short and the form of sensorineural and vascular pathology mimics that found frequently in humans (Paigen et al., 1987; Li, 1992) . In the past 25 years, over 700 published articles have described various aspects of the auditory system of the mouse (Henry and McGinn, 1992) . However, few reports have described cochlear blood flow (CBF) in mice, probably because of the small size of the cochlea and the unavailability of appropriate measurement technology until relatively recently. In this study CBF was measured using laserDoppler flowmetry in mice and the effect of aging on CBF response to systemically and topically applied vasodilating agents was investigated.
Materials and methods
The subjects for this investigation included thirtynine 2-month-old CBA mice (10 female. 29 male). three lo-month-old CBA mice (all male) and three 18-month-old CBA mice (all male). 2-month-old CBA mice were obtained from Jackson laboratories and the aged mice were obtained from National Institute of Aging. The animals were anesthetized with subcutaneous Ketamine (100 mg/kg) and Rompun (10 mg/kg), which was supplemented every 30 min with Ketamine (50 mg/kg). Core body temperature, measured with a rectal probe, was maintained at 37 + 1°C with a thermoregulated heating blanket. Blood pressure (BP) in 21 of the mice was measured indirectly from the tail with the aid of a hydraulic occluder (Vascular Occluder, In Vivo Metric, CA) positioned close to the body. The vascular occluder had a 5 mm lumen diameter and 7 mm width. Water injected into the cuff tubing occluded the tail artery, while tail blood flow was measured by laser-Doppler flowmeter (TSI Laser Flo or Perimed Periflux). After the cuff pressure was increased sufficiently to occlude all distal flow in the tail, systolic BP was measured by deflating the cuff until blood flow began to return. BP was measured at several minute intervals in all except one of the animals in which vasodilating agents were administered subcutaneously, and in the 6 animals that received topical application of the drugs. In one animal, the relationship between systolic BP measured by the tail cuff method and mean BP measured directly via a cannula (PElO) inserted into the left femoral artery was determilled while BP was altered by subcutaneous injection of phenylephrin and hydralazine. In two animals, left carotid BP was measured directly through a cannula (PElO).
The right tympanic bulla of each animal was opened via a ventral approach. After gently removing the middle ear mucosa from the surface of the cochlea, a laser-Doppler probe was placed over the lateral wall of the cochlea to measure CBF. The diameter of the probe was 0.4 mm (Perimed PF2) or 0.8 mm (TSI Laser FIo). The smaller diameter probe was used in 12 of 27 animals in which vasodilating agents were administered topically. Although the smalier probe gives a CBF reading from a smaller measurement volume, the percentage change in flow for a drug stimulus was not altered by the probe size. A light petroleum gel was used to maintain a good optical coupling between the probe and the cochlea. The gel prevented fluid accumuiation and extraneous red cells from moving under the probe. All recordings were done under stable illumination from the operating microscope.
Three vasodilating agents were investigated: sodium nitroprusside, hydralazine and pentoxifylline were applied topically or subcutaneously. Sodium nitroprusside and hydralazine are powerful vasodilators that increase nitric oxide (NO) which has recently been identified as an endothelium-derived relaxing factor (Ignarro, 1989) . Sodium nitroprusside acts on the smooth muscle of both arterioles and venules, while hydralazine is a pure arterioiar dilator ~Shepherd and Irvine, 1986). Pentoxifylhne has a small vasodilator effect (Kaapa et al., 1991; Sonkin et al., 1992) , although the most important function of pentoxifylline for improving blood flow is the result of an increase in red blood cell flexibility. To administer the vasodilating agents topically, 0.4 to 2.0 ,~l quantities of agents diluted in saline were applied to the round window (RW) niche by a microsyringe. Dose-response functions were determined on the basis of total drug weight apphed to the RW (concentration of the drug times volume of the solution).
Sodium nitrop~sside was applied topically in fourteen 2-month-old mice (12 males and 2 females), two lo-month-old mice and two l&month-old mice. The concentration of sodium nitroprusside applied topically was 0.01553.0%. In some cases of topical application of sodium nitroprusside, it was dissolved in distilled water to lower the osmolarity. Osmolarity of 3% sodium nitroprusside dissolved in saline and distilled water was 534 mOsm and 273 mOsm, respectively. Acidity of 3% sodium nitroprusside was pH 5.1-5.2 in either solution. For systemic administration of sodium nitroprusside, 0.2 mg/kg or 2 mg/kg was injected subcutaneously in six 2-month-old mice (all males), one IO-month-old mouse and one 18 month-old mouse.
For topica application of hydralazine, nine Imonth-old mice (6 males and 3 females) were used. The concentration of hydrafazine applied topicaliy was 0.02-4.0%. Two percent hydralazine dissolved in saline was 384 mOsm and pH 3.9. For systemic administration of hydralazine, 0.2 mg/kg or 2 mg/kg was injected subcutaneously in five 2-month-old mice (3 males and 2 females).
For application of pentoxifylline, 5% pentoxifylline was applied topically in three 2-month-old mice (2 females and one male). Because CBF did not change following the topical application, subsequent injection of 50 mg/kg or 100 mg/kg pentoxi~lline was performed subcutaneously, In one female 2-month-old mouse, 50 mg/kg pentoxifylline was injected subcutaneously without prior topical application of pentoxifylline.
Changes in CBF are expressed as relative change in blood flow from an initial baseline. The value of the baseline level of CBF before the administration of the drug was considered as lOO%, and percentage change in CBF was plotted foilowing the administration. nula inserted into a femoral artery (Fig. 1) . The correlation coefficient of the linear regression was 0.94. The mean femoral BP was approximately 30% lower than the systolic BP measured via the tail cuff. BP measured by the cuff method immediately before drugs were applied was 116.3 if: 31.8 mmHg in young mice (2-month-old, N = 16) and 116.5 & 13.4 mmHg in the aged mice (lo-or l&month-old, N = 4). Sodium nitroprusside applied to the RW niche elevated CBF in a dose dependent manner. Fig. 2 is a representative example, showing that one minute foilowing topical application of a moderate and high dose of sodium nitroprusside, CBF began to increase and reached a maximum level within about lo-15 min. Because anesthesia time was restricted in mice (about 2 hours), it was not possible to observe CBF for a long time. However, there was no obvious recovery from these topically induced increases during the entire duration of the experiment. Fig. 3 shows the dose-response CBF function obtained for topically applied sodium nitroprusside in 18 animals. There was no significant change in response to topical sodium nitroprusside between young and aged mice. There was also no significant change in response between male and female mice. No difference in response was observed dependent on the vehicle used (saline or distilled water). In six animals, BP was measured before and after sodium nitroprusside was applied topically. No consistent change of BP was observed. in 2-10 min following injection. Both tend toward recovery. With 0.2 mg/kg sodium nitroprusside, BP still showed a 15-3.5% decrease but the increase in CBF was under about lo-20% (Fig. 5) . These data indicate that the sodium nitroprusside effect on peripheral vessels is relatively saturated at these doses (i.e., similar BP decreases) while the dila-CBF (%) tion of cochlear vessels is not. One l&month-old mouse died 20 min after subcutaneous injection of 0.2 mg/kg sodium nitroprusside. Hydralazine applied to the RW niche also increased CBF in a dose dependent manner. CBF began to increase 2 or 3 min after the application of hydralazine, and reached a maximum level within 10 min. Generally speaking, the CBF changes caused by topically applied hydralazine were similar to those of sodium nitroprusside.
Results

Systolic
However, in two cases that showed an increase in CBF of less than 40% following application of the drug, CBF began to return toward the baseline within 30 min following the peak response level. The relationship between the total weight of hydralazine applied topically and the maximum response observed in CBF is shown in Fig. 6 . There was no significant difference in response between males and females. We also did not find any difference in the response to topical application of sodium nitroprusside based on the diameter of probe (0.4 mm or 0.8 mm).
The effect of subcutaneously injected hydralazine (0.2 mg/kg or 2 mg/kg) on CBF is shown in Fig. 7 . An increase in CBF was observed in 1 of 3 animals administered 0.2 mg/kg hydralazine and in 1 of 2 animals receiving 2 mg/kg hydralazine.
In the 2 animals in which CBF increased following subcutaneous injection of hydralazine, BP was measured directly through a cannula inserted into the carotid artery.
Pentoxifylline did not increase CBF when 30-50 mg was applied topically to the RW niche in 3 animals. When pentoxifylline was injected subcutaneously (50 mg/kg or 100 mg/kg), CBF increased by lo-20% within approximately 5 min in 3 of 4 animals without significant change of BP (Fig. 8) . This CBF increase appeared to recover to baseline within 20 min of the subcutaneous injection (3 of 4 animals).
Discussion
It was possible to measure CBF in the mouse using laser-Doppler flowmetry. It thus appears that the status of CBF in various genetic mouse models of sensorineural hearing loss can be studied to investigate the role of CBF disturbance in inner ear deafness. The other advantage of the mouse rests with the availability of aged mice to study the relationship of CBF and functional changes in the inner ear with aging. Disadvantages of mice in the investigation of CBF are difficulty with cannulation of arteries or veins for BP measurement or drug administration, and difficulties with maintaining this small animal in a good physiological state for extended periods under anesthesia. This is generally due to respiratory deterioration. To reduce the experiment time in the current study, a cuff method for measurement of BP of the tail artery was used in these studies. The cuff method has been widely used in many strains of young and aged mice for measurement of BP (Schlager, 1966; Weibust and Schlager, 1968) . These studies showed that age related changes in BP may be quite different from strain to strain. In the CBA strain of mice, no increase of BP was observed with age after maturation (Henry et al.. 1965 ). In the current study using CBA strain, the average BP was not different between young and aged mice.
We investigated the effect of 3 vasodilating agents: sodium nitroprusside, hydralazine and pentoxifylline on CBF in mice. Sodium nitroprusside and hydralazine, as powerful vasodilators, are used to lower severe hypertension.
Sodium nitroprusside demonstrated a more pronounced effect on BP than CBF. This may be related to the generally powerful effect of nitric oxide as a vasodilator.
Considering the facts that the amount of sodium nitroprusside required to increase CBF in mice exceeds clinical dosage per body weight and that the clinical dosage of sodium nitroprusside typically used does not increase cerebral blood flow (Tinker and Michenfelder, 1976; Ivankovich et al.. lY76) , it is possible that systemic administration of sodium nitroprusside would not increase CBF to a clinically useful degree.
Hydralazine did not increase CBF except in two cases. It is not clear why this was so. The effect ot hydralazine on CBF has been studied earlier by Snow and Suga (1973) using impedance plethysmography in guinea pigs. They reported an increase of CBF with a drop in BP following intravenous injection of hydralazine. Miller et al. (1986) and Ohlsen et al. (IYY2) . however, reported no increase in CBF using Iaser-Doppler flowmetry in guinea pigs, combined with ;I decrease in BP following systemic administration of hydralazine. This must mean that some cochlear vasodilation occurred to counteract the decreased systemic BP. Overall, the influence of systemically administered vasodilating agents on CBF is complicated by the dilatation of blood vessels in the whole body and the concomitant hypotension. Effects of aging on CBF are important in relation to presbycusis (Johnsson and Hawkins, 1976; Gates et al., 1993) . Prazma et al. (1990) reported that CBF decreased in 2-to 3-year old gerbils. Hillerdal et al. (1987) , however, observed that CBF in 8-to 24-monthold normotensive rats was not significantly different from that found in 3-to 6-month-old normotensive rats.
The effect of age on CBF may be different in each animal according to its life span. Because life span of the mouse is short (about two years) and many aging studies have been performed in mice, we suggest that the mouse is a useful model to extend our knowledge of the basis for and the role of CBF in age related hearing changes of presbycusis. Ignarro, L.J. (1989) 
